118 related articles for article (PubMed ID: 9855464)
1. Tumor expression studies indicate that HEM-1 is unlikely to be the active factor in oncogenic osteomalacia.
Nelson AE; Mason RS; Hogan JJ; Diamond T; Robinson BG
Bone; 1998 Dec; 23(6):549-53. PubMed ID: 9855464
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of tumor cell bioactivity in oncogenic osteomalacia.
Nelson AE; Namkung HJ; Patava J; Wilkinson MR; Chang AC; Reddel RR; Robinson BG; Mason RS
Mol Cell Endocrinol; 1996 Nov; 124(1-2):17-23. PubMed ID: 9027320
[TBL] [Abstract][Full Text] [Related]
3. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia.
Nelson AE; Bligh RC; Mirams M; Gill A; Au A; Clarkson A; Jüppner H; Ruff S; Stalley P; Scolyer RA; Robinson BG; Mason RS; Bligh PC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4088-94. PubMed ID: 12970268
[TBL] [Abstract][Full Text] [Related]
4. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.
Rowe PS; de Zoysa PA; Dong R; Wang HR; White KE; Econs MJ; Oudet CL
Genomics; 2000 Jul; 67(1):54-68. PubMed ID: 10945470
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolite levels in oncogenic osteomalacia.
Sweet RA; Males JL; Hamstra AJ; DeLuca HF
Ann Intern Med; 1980 Aug; 93(2):279-80. PubMed ID: 7406381
[TBL] [Abstract][Full Text] [Related]
6. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
7. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
Ryan WG; Gitelis S; Charters JR
Calcif Tissue Int; 1986 Jun; 38(6):358-62. PubMed ID: 3089559
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of renal epithelial phosphate transport in tumor-induced osteomalacia and uremia.
Kumar R; Haugen JD; Wieben ED; Londowski JM; Cai Q
Proc Assoc Am Physicians; 1995 Oct; 107(3):296-305. PubMed ID: 8608414
[TBL] [Abstract][Full Text] [Related]
9. Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia.
Toyosawa S; Tomita Y; Kishino M; Hashimoto J; Ueda T; Tsujimura T; Aozasa K; Ijuhin N; Komori T
Mod Pathol; 2004 May; 17(5):573-8. PubMed ID: 15001995
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia.
Ohashi K; Ohnishi T; Ishikawa T; Tani H; Uesugi K; Takagi M
Skeletal Radiol; 1999 Jan; 28(1):46-8. PubMed ID: 10068075
[TBL] [Abstract][Full Text] [Related]
12. Identification of PCAG1 as a novel prostate cancer-associated gene.
Lai Y; Yu Z; Wang Y; Ye J
Mol Med Rep; 2013 Mar; 7(3):755-60. PubMed ID: 23292432
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
Fukumoto S; Takeuchi Y; Nagano A; Fujita T
Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
[TBL] [Abstract][Full Text] [Related]
14. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism.
De Beur SM; Finnegan RB; Vassiliadis J; Cook B; Barberio D; Estes S; Manavalan P; Petroziello J; Madden SL; Cho JY; Kumar R; Levine MA; Schiavi SC
J Bone Miner Res; 2002 Jun; 17(6):1102-10. PubMed ID: 12054166
[TBL] [Abstract][Full Text] [Related]
15. Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone.
Argiro L; Desbarats M; Glorieux FH; Ecarot B
Genomics; 2001 Jun; 74(3):342-51. PubMed ID: 11414762
[TBL] [Abstract][Full Text] [Related]
16. Effects of tumor-induced osteomalacia on the bone mineralization process.
Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
[TBL] [Abstract][Full Text] [Related]
17. Occult nasal sinus tumours causing oncogenic osteomalacia.
Kenealy H; Holdaway I; Grey A
Eur J Intern Med; 2008 Nov; 19(7):516-9. PubMed ID: 19013380
[TBL] [Abstract][Full Text] [Related]
18. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
Miyauchi A; Fukase M; Tsutsumi M; Fujita T
J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic osteomalacia.
Rapoport J
Isr Med Assoc J; 2000 Dec; 2(12):942-3. PubMed ID: 11344782
[No Abstract] [Full Text] [Related]
20. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
